287 related articles for article (PubMed ID: 35805984)
41. On the mechanisms underlying activation and reversal of high altitude-induced pulmonary hypertension in humans - Another piece in the pulmonary puzzle.
Berger MM; Bailey DM
Exp Physiol; 2023 Jan; 108(1):1-4. PubMed ID: 36409273
[No Abstract] [Full Text] [Related]
42. Increases in mitochondrial reactive oxygen species trigger hypoxia-induced calcium responses in pulmonary artery smooth muscle cells.
Waypa GB; Guzy R; Mungai PT; Mack MM; Marks JD; Roe MW; Schumacker PT
Circ Res; 2006 Oct; 99(9):970-8. PubMed ID: 17008601
[TBL] [Abstract][Full Text] [Related]
43. Mitochondrial ROS-PKCepsilon signaling axis is uniquely involved in hypoxic increase in [Ca2+]i in pulmonary artery smooth muscle cells.
Rathore R; Zheng YM; Li XQ; Wang QS; Liu QH; Ginnan R; Singer HA; Ho YS; Wang YX
Biochem Biophys Res Commun; 2006 Dec; 351(3):784-90. PubMed ID: 17087917
[TBL] [Abstract][Full Text] [Related]
44. Recent advances in oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction.
Strielkov I; Pak O; Sommer N; Weissmann N
J Appl Physiol (1985); 2017 Dec; 123(6):1647-1656. PubMed ID: 28751366
[TBL] [Abstract][Full Text] [Related]
45. Hypoxic pulmonary vasoconstriction.
Moudgil R; Michelakis ED; Archer SL
J Appl Physiol (1985); 2005 Jan; 98(1):390-403. PubMed ID: 15591309
[TBL] [Abstract][Full Text] [Related]
46. CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction.
Tabeling C; Yu H; Wang L; Ranke H; Goldenberg NM; Zabini D; Noe E; Krauszman A; Gutbier B; Yin J; Schaefer M; Arenz C; Hocke AC; Suttorp N; Proia RL; Witzenrath M; Kuebler WM
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1614-23. PubMed ID: 25829545
[TBL] [Abstract][Full Text] [Related]
47. Roles of different mitochondrial electron transport chain complexes in hypoxia-induced pulmonary vasoconstriction.
Yang Z; Zhuan B; Yan Y; Jiang S; Wang T
Cell Biol Int; 2016 Feb; 40(2):188-95. PubMed ID: 26454147
[TBL] [Abstract][Full Text] [Related]
48. Notch Activation of Ca(2+) Signaling in the Development of Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension.
Smith KA; Voiriot G; Tang H; Fraidenburg DR; Song S; Yamamura H; Yamamura A; Guo Q; Wan J; Pohl NM; Tauseef M; Bodmer R; Ocorr K; Thistlethwaite PA; Haddad GG; Powell FL; Makino A; Mehta D; Yuan JX
Am J Respir Cell Mol Biol; 2015 Sep; 53(3):355-67. PubMed ID: 25569851
[TBL] [Abstract][Full Text] [Related]
49. Hypoxic pulmonary vasoconstriction.
Sylvester JT; Shimoda LA; Aaronson PI; Ward JP
Physiol Rev; 2012 Jan; 92(1):367-520. PubMed ID: 22298659
[TBL] [Abstract][Full Text] [Related]
50. Sirtuin 3 deficiency does not augment hypoxia-induced pulmonary hypertension.
Waypa GB; Osborne SW; Marks JD; Berkelhamer SK; Kondapalli J; Schumacker PT
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):885-91. PubMed ID: 24047466
[TBL] [Abstract][Full Text] [Related]
51. Roles for Nox4 in the contractile response of bovine pulmonary arteries to hypoxia.
Ahmad M; Kelly MR; Zhao X; Kandhi S; Wolin MS
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1879-88. PubMed ID: 20304813
[TBL] [Abstract][Full Text] [Related]
52. Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox).
Liu JQ; Zelko IN; Erbynn EM; Sham JS; Folz RJ
Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L2-10. PubMed ID: 16085672
[TBL] [Abstract][Full Text] [Related]
53. The vein utilizes different sources of energy than the artery during pulmonary hypoxic vasoconstriction.
Zhao Y; Packer CS; Rhoades RA
Exp Lung Res; 1996; 22(1):51-63. PubMed ID: 8838135
[TBL] [Abstract][Full Text] [Related]
54. Hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries is not inhibited by antagonists of H2 S-synthesizing pathways.
Prieto-Lloret J; Shaifta Y; Ward JP; Aaronson PI
J Physiol; 2015 Jan; 593(2):385-401. PubMed ID: 25630260
[TBL] [Abstract][Full Text] [Related]
55. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension.
Moudgil R; Michelakis ED; Archer SL
Microcirculation; 2006 Dec; 13(8):615-32. PubMed ID: 17085423
[TBL] [Abstract][Full Text] [Related]
56. Modulation of the LKB1-AMPK Signalling Pathway Underpins Hypoxic Pulmonary Vasoconstriction and Pulmonary Hypertension.
Evans AM; Lewis SA; Ogunbayo OA; Moral-Sanz J
Adv Exp Med Biol; 2015; 860():89-99. PubMed ID: 26303471
[TBL] [Abstract][Full Text] [Related]
57. PKCĪµ mediates resistin-induced NADPH oxidase activation and inflammation leading to smooth muscle cell dysfunction and intimal hyperplasia.
Raghuraman G; Zuniga MC; Yuan H; Zhou W
Atherosclerosis; 2016 Oct; 253():29-37. PubMed ID: 27573736
[TBL] [Abstract][Full Text] [Related]
58. Smooth muscle acid-sensing ion channel 1: pathophysiological implication in hypoxic pulmonary hypertension.
Jernigan NL
Exp Physiol; 2015 Feb; 100(2):111-20. PubMed ID: 25398716
[TBL] [Abstract][Full Text] [Related]
59. Protein kinase C-epsilon-null mice have decreased hypoxic pulmonary vasoconstriction.
Littler CM; Morris KG; Fagan KA; McMurtry IF; Messing RO; Dempsey EC
Am J Physiol Heart Circ Physiol; 2003 Apr; 284(4):H1321-31. PubMed ID: 12505875
[TBL] [Abstract][Full Text] [Related]
60. Raisanberine protected pulmonary arterial rings and cardiac myocytes of rats against hypoxia injury by suppressing NADPH oxidase and calcium influx.
Gao J; Tang YQ; Dai DZ; Cheng YS; Zhang GL; Zhang C; Dai Y
Acta Pharmacol Sin; 2012 May; 33(5):625-34. PubMed ID: 22555370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
